Filing Details
- Accession Number:
- 0001209191-21-024705
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-02 17:19:22
- Reporting Period:
- 2021-04-01
- Accepted Time:
- 2021-04-02 17:19:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1770787 | 10X Genomics Inc. | TXG | Laboratory Analytical Instruments (3826) | 455614458 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1786391 | J. Benjamin Hindson | C/O 10X Genomics, Inc. 6230 Stoneridge Mall Road Pleasanton CA 94588 | See Remarks | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2021-04-01 | 41,666 | $1.07 | 78,302 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2021-04-01 | 800 | $179.98 | 77,502 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2021-04-01 | 600 | $181.50 | 76,902 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2021-04-01 | 1,900 | $182.48 | 75,002 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2021-04-01 | 6,686 | $183.74 | 68,316 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2021-04-01 | 16,748 | $184.53 | 51,568 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2021-04-01 | 14,632 | $185.52 | 36,936 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2021-04-01 | 300 | $186.08 | 36,636 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Stock Option (right to buy) | Disposition | 2021-04-01 | 41,666 | $0.00 | 41,666 | $1.07 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 78,032 | 2026-11-18 | No | 4 | M | Direct |
Footnotes
- The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
- This transaction was executed in multiple trades at prices ranging from $179.80 to $180.22. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $180.96 to $181.91. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $181.96 to $182.90. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $183.02 to $184.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $184.02 to $185.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $185.02 to $185.99. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $186.005 to $186.15. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- All of the shares subject to the option are fully vested and exercisable as of the date hereof.
Billionaire Hedge Funds
